Skip to main content
Smart Investors Daily
Centene Corporation logo

NYSE · CNC

Centene Corporation

Healthcare · Medical - Healthcare Plans

$65.11

Down-$1.99 (-2.97%)

Updated Sep 20, 2026, 3:18 PM

SID Score

6.7/10

Composite research score

Smart Money

58/100

Neutral

Market cap
19.89B
P/E ratio
-3.76
Dividend yield
0.00%
52-week range
$31.63 – $69.63
Volume
13.45M
Avg. volume
10.62M

Price performance

CNC price history

1M range · 19 trading sessions · Daily adjusted prices

CNC closed at $65.11 after 19 trading sessions, down 0.82% for the selected period.

Last close
$65.11
Period change
-0.82%
Period low
$64.06
Period high
$69.41
Daily close
View OHLC price history
CNC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 18, 2026$66.89$67.73$65.03$65.1113.45M
Sep 17, 2026$66.63$67.79$65.76$67.105.13M
Sep 16, 2026$68.40$69.41$66.01$66.014.28M
Sep 15, 2026$68.50$68.62$67.05$67.663.58M
Sep 14, 2026$67.31$69.63$67.15$69.414.1M
Sep 11, 2026$65.70$66.85$64.52$66.423.63M
Sep 10, 2026$65.50$68.205$65.26$65.404.63M
Sep 9, 2026$64.44$64.84$61.81$64.064.48M
Sep 8, 2026$66.16$66.50$64.50$64.584.35M
Sep 4, 2026$66.77$68.22$66.7675$67.042.93M
Sep 3, 2026$67.50$68.83$66.85$68.023.59M
Sep 2, 2026$65.40$67.885$65.40$67.344.83M
Sep 1, 2026$64.72$66.47$64.69$65.234.56M
Aug 31, 2026$65.39$65.39$63.42$64.348.79M
Aug 28, 2026$65.41$65.74$64.28$64.752.53M
Aug 27, 2026$65.04$66.21$64.66$65.333.65M
Aug 26, 2026$65.00$67.68$64.98$65.473.6M
Aug 25, 2026$65.95$65.95$64.60$65.004.34M
Aug 24, 2026$64.79$66.10$64.52$65.653.49M

Latest CNC news

The latest Smart Investors Daily articles mentioning CNC.

CNC research

Overview

Company profile and research snapshot.

Company profile

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$42.00
Implied upside
Analysts
26
CNC recent ratings
DateFirmRatingTarget
Aug 11, 2026Argus ResearchBuy
Aug 4, 2026JP MorganNeutral
Aug 3, 2026BernsteinOutperform
Jul 29, 2026BarclaysOverweight
Jul 29, 2026BairdNeutral
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 18, 2026

Centene (CNC) Could Be 6% Undervalued Following Renewed Interest In Earnings And ICHRA Growth

Centene (CNC) has moved back into focus after being highlighted for its earnings expectations, an attractive valuation profile, and exposure to growing ICHRA-driven individual coverage through its Ambetter Health Solutions business. Centene’s recent momentum has been hard to ignore, with a 90 day share price return of 9.96% feeding into a 60.60% year to date gain and a 1 year total shareholder return of 108.58%. This suggests investors are reassessing both its earnings profile and perceived...

Yahoo · Sep 18, 2026

Is Centene (CNC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.